Revisiting Competition Issues in the Follow-On Biologics Arena: State Substitution and Naming Conventions
Webinar Recorded on July 16, 2014
AMCP is pleased to present Elizabeth Jex, Attorney Advisor in the Office of Policy and Planning, at the Federal Trade Commission who will discuss the impact of state laws on biosimilars and naming conventions on the future of access and competition to these agents in the marketplace. Participants will also receive a forecast of legislative and regulatory actions related to biosimilars likely to occur in the second half of 2014 and beyond.
(formerly titled: Biosimilars: Latest on State and Federal Legislative and Regulatory Activity)
For AMCP Members Only
- Elizabeth Jex, Attorney Advisor in the Office of Policy and Planning, Federal Trade Commission
- Mary Jo Carden, Senior Director of Regulatory Affairs, AMCP
- Lauren Fuller, VP of Government Affairs, AMCP